Physician profile
Daniel Enright
NPI 1629530746
$19,885.00
in general payments reported to CMS, 2019-2025
8 companies · $7,072 in 2025
The $7,072 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $847 · 2021: $2,421 · 2022: $3,171 · 2023: $209 · 2024: $6,166 · 2025: $7,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $2,150 · Food and Beverage: $1,051 · Education: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $2,149.92 |
| Food and Beverage | $1,051.01 |
| Education | $245.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,000.00 | 2024-2025 | |
| Stryker Corporation | $5,982.15 | 2022-2025 | Mako, Insignia, Triathlon |
| Rock Medical Orthopedics, INC. | $3,267.83 | 2020-2021 | |
| Becton, Dickinson and Company | $295.10 | 2022-2024 | Arista Ah Flexitip |
| Medical Device Business Services, INC. | $229.99 | 2024 | |
| Illuminoss Medical, INC. | $37.52 | 2024 | |
| Medacta USA, INC. | $37.32 | 2022 | |
| Depuy Synthes Sales INC. | $35.09 | 2025 | Na, Motoband |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Enright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.